Immunoprecise Antibodies Stock Price Prediction
| IPA Stock | USD 0.56 0.01 1.75% |
Oversold Vs Overbought
34
Oversold | Overbought |
EPS Estimate Current Year (0.34) | EPS Estimate Next Year (0.25) | Wall Street Target Price 5.97 | EPS Estimate Current Quarter (0.08) | Quarterly Revenue Growth (0.07) |
Using Immunoprecise Antibodies hype-based prediction, you can estimate the value of Immunoprecise Antibodies from the perspective of Immunoprecise Antibodies response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Immunoprecise Antibodies to buy its stock at a price that has no basis in reality. In that case, they are not buying Immunoprecise because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Immunoprecise Antibodies after-hype prediction price | USD 0.59 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Immunoprecise |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunoprecise Antibodies' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunoprecise Antibodies After-Hype Price Prediction Density Analysis
As far as predicting the price of Immunoprecise Antibodies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Immunoprecise Antibodies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Immunoprecise Antibodies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Immunoprecise Antibodies Estimiated After-Hype Price Volatility
In the context of predicting Immunoprecise Antibodies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Immunoprecise Antibodies' historical news coverage. Immunoprecise Antibodies' after-hype downside and upside margins for the prediction period are 0.03 and 8.31, respectively. We have considered Immunoprecise Antibodies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Immunoprecise Antibodies is dangerous at this time. Analysis and calculation of next after-hype price of Immunoprecise Antibodies is based on 3 months time horizon.
Immunoprecise Antibodies Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Immunoprecise Antibodies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Immunoprecise Antibodies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Immunoprecise Antibodies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.35 | 7.66 | 0.03 | 0.00 | 10 Events / Month | 16 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.56 | 0.59 | 5.36 |
|
Immunoprecise Antibodies Hype Timeline
On the 17th of October 2024 Immunoprecise Antibodies is traded for 0.56. The entity has historical hype elasticity of 0.03, and average elasticity to hype of competition of 0.0. Immunoprecise is projected to increase in value after the next headline, with the price projected to jump to 0.59 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 5.36%, whereas the daily expected return is currently at -0.35%. The volatility of related hype on Immunoprecise Antibodies is about 168520.0%, with the expected price after the next announcement by competition of 0.56. Immunoprecise Antibodies has about 19.24 M in cash with (4.25 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.77, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Considering the 90-day investment horizon the next projected press release will be in about 10 days. Check out Immunoprecise Antibodies Basic Forecasting Models to cross-verify your projections.Immunoprecise Antibodies Related Hype Analysis
Having access to credible news sources related to Immunoprecise Antibodies' direct competition is more important than ever and may enhance your ability to predict Immunoprecise Antibodies' future price movements. Getting to know how Immunoprecise Antibodies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Immunoprecise Antibodies may potentially react to the hype associated with one of its peers.
Immunoprecise Antibodies Additional Predictive Modules
Most predictive techniques to examine Immunoprecise price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Immunoprecise using various technical indicators. When you analyze Immunoprecise charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Immunoprecise Antibodies Predictive Indicators
The successful prediction of Immunoprecise Antibodies stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Immunoprecise Antibodies, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Immunoprecise Antibodies based on analysis of Immunoprecise Antibodies hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Immunoprecise Antibodies's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Immunoprecise Antibodies's related companies. | 2020 | 2021 | 2022 | 2023 (projected) | Payables Turnover | 2.12 | 1.76 | 2.69 | 2.85 | Days Of Inventory On Hand | 68.95 | 70.33 | 82.61 | 62.63 |
Story Coverage note for Immunoprecise Antibodies
The number of cover stories for Immunoprecise Antibodies depends on current market conditions and Immunoprecise Antibodies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Immunoprecise Antibodies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Immunoprecise Antibodies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Immunoprecise Antibodies Short Properties
Immunoprecise Antibodies' future price predictability will typically decrease when Immunoprecise Antibodies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Immunoprecise Antibodies often depends not only on the future outlook of the potential Immunoprecise Antibodies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Immunoprecise Antibodies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 25.6 M | |
| Cash And Short Term Investments | 3.5 M |
Complementary Tools for Immunoprecise Stock analysis
When running Immunoprecise Antibodies' price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |